Diagnosis and Management of Elevated Ferritin in Fatty Liver and Inflammation

Introduction to Elevated Ferritin

• Transferrin saturation <45% effectively excludes primary iron overload in over 90% of cases, making hereditary hemochromatosis extremely unlikely 3, 1, 2.
• The most common causes of hyperferritinemia include chronic inflammation, fatty liver disease/metabolic syndrome, and cell necrosis—these account for over 90% of cases in outpatients 1.

Diagnostic Framework

• The American Association for the Study of Liver Diseases explicitly states that fasting transferrin saturation is the test of choice for screening, and values <45% require no further genetic evaluation 3, 2.
• HFE genetic testing is ONLY indicated when transferrin saturation ≥45% with elevated ferritin 3, 1, 2.

Management of Elevated Ferritin

• Phlebotomy is ONLY indicated for confirmed iron overload with transferrin saturation ≥45% and evidence of end-organ damage 3, 1, 2.
• The treatment target is the underlying liver disease (NAFLD/metabolic syndrome), not the elevated ferritin itself 1, 2.
• Ferritin levels are significantly correlated with insulin resistance and age in patients with fatty liver, independent of iron stores 1.

Monitoring and Follow-up

• Ferritin should be monitored every 3 months as a marker of treatment response—declining ferritin indicates improvement in underlying inflammation and metabolic dysfunction 4.
• Ferritin <1,000 μg/L has a 94% negative predictive value for advanced liver fibrosis, indicating very low risk of cirrhosis 1, 2.

Critical Pitfalls to Avoid

• Never use ferritin alone without transferrin saturation to diagnose iron overload—this leads to misdiagnosis and inappropriate phlebotomy 1, 2.
• Do not assume iron overload when transferrin saturation <45%—over 90% of elevated ferritin cases are due to secondary causes 1, 2.
• Do not perform therapeutic phlebotomy without confirmed iron overload (transferrin saturation ≥45% and evidence of end-organ damage) 1, 2.